Quell Therapeutics is the world leader in developing engineered T-regulatory (Treg) cell therapies that aim to harness, direct and optimize their immune suppressive properties to address serious medical conditions driven by the immune system.
Location: United Kingdom, England, London
Member count: 51-200
Total raised: $284.594103M
Founded date: 2019
Investors 3
| Date | Name | Website |
| 15.12.2021 | Jeito Capi... | jeito.life |
| 02.05.2022 | British Pa... | britishpat... |
| - | Syncona Pa... | synconaltd... |
Funding Rounds 3
| Date | Series | Amount | Investors | Deal News |
| 22.12.2021 | Series B | $156M | Jeito Capi... | marketscre... |
| 15.02.2021 | Series A | $84.046592... | - | uktech.new... |
| 20.05.2019 | Series A | $44.547511... | - | finsmes.co... |
Mentions in press and media 23
| Date | Title | Description | Category | Author | Source |
| 09.06.2023 | Quell Ther... | London, UK – June 9 2023 – Que... | - | - | svhealthin... |
| 21.11.2022 | Quell Ther... | Adds significant clinical, tra... | - | - | einpresswi... |
| 30.11.2021 | Quell Ther... | Quell is harnessing the full... | - | - | ucltf.co.u... |
| 30.11.2021 | London's Q... | Biotech startup Quell Therapeu... | - | - | pitchbook.... |
| 29.11.2021 | Next-gen C... | Fierce 15 winner Quell Therape... | Biotech | - | fiercebiot... |
| 29.11.2021 | Cell thera... | Organ transplants require drug... | - | - | medcitynew... |
| 29.11.2021 | Quell Ther... | Quell Therapeutics Ltd, a Lond... | UK USA | - | finsmes.co... |
| 29.11.2021 | Jeito Capi... | Jeito Capital co-leads $156 mi... | - | - | globenewsw... |
| 29.11.2021 | Syncona : ... | - Series B co-led by Jeito Cap... | - | - | marketscre... |
| 29.11.2021 | Next-gen C... | Fierce 15 winner Quell Therape... | Biotech | - | fiercebiot... |
Show more